Purchase Order 75N92019P00390

<p>The National Institute of Biomedical Imaging and Bioengineering awarded a purchase order to Coherent Inc. for a Coherent 488 nm laser and 561 nm OBIS laser, valued at $15,440.00, with an award date of July 17, 2017. The order carries no set-aside designation. Place of performance is Bethesda, Maryland. The ultimate completion date is October 17, 2017.</p>

<p>The National Institute of Biomedical Imaging and Bioengineering awarded a purchase order to Coherent Inc. for $22,837.30 on March 13, 2018, covering three coherent lasers: an OBIS 405NM LX 100MW laser, an OBIS 488NM LS 150MW laser, and an OBIS 561NM LS 150MW laser. Performance occurs at Bethesda, Maryland, with completion required by April 30, 2018. The order carries firm fixed pricing and uses no small business set-aside.</p>

<p>The National Human Genome Research Institute issued a $24,926.45 delivery order to Illumina, Inc. on September 19, 2019, under a firm fixed-price structure.</p> <p>Place of performance is Bethesda, MD. The order was due for completion on September 2, 2020. No set-aside was applied to this delivery order.</p>

<p>The National Human Genome Research Institute issued a $15,321.60 delivery order to Illumina, Inc. on July 18, 2019, for genetic sequencing equipment and related genomic analysis technologies.</p> <p>Place of performance is Bethesda, MD. The order has a firm fixed-price structure with an ultimate completion date of September 2, 2020. No set-aside was used for this award.</p>

<p>The National Human Genome Research Institute issued a $13,029.68 delivery order to Illumina, Inc. on September 12, 2017, for genetic sequencing and genomic analysis equipment and supplies.</p> <p>Place of performance is North Bethesda, Maryland. The order has a firm fixed-price structure and an ultimate completion date of October 11, 2017. No set-aside was used.</p>

<p>The National Human Genome Research Institute (National Institutes of Health) awarded a purchase order to Illumina, Inc. valued at $208,735.16 on June 5, 2026, for firm fixed-price procurement with no set-aside designation. Work is performed in San Diego, California. The order is scheduled for ultimate completion by September 22, 2027.</p>

<p>The National Human Genome Research Institute issued a delivery order to Illumina, Inc. on August 1, 2017, with a ceiling value of $5,273.81 under a firm fixed-price arrangement.</p> <p>Place of performance is North Bethesda, MD. The order has an ultimate completion date of September 1, 2017. No set-aside was used for this delivery order.</p>

<p>The National Human Genome Research Institute issued a $149,618.50 delivery order to Illumina, Inc., on September 1, 2017, for genetic sequencing and genomic analysis technologies.</p> <p>Place of performance is North Bethesda, MD. The order has a firm fixed-price structure with an ultimate completion date of September 30, 2017.</p>

<p>The National Human Genome Research Institute issued a $122,145.01 delivery order to Illumina, Inc. on September 15, 2017, for genetic sequencing and genomic analysis technologies.</p> <p>Place of performance is Bethesda, MD 20892. The order has a firm fixed-price structure with an ultimate completion date of December 15, 2017. No set-aside was used.</p>

The National Human Genome Research Institute issued a delivery order to Becton, Dickinson and Company on October 31, 2019, with a ceiling value of $32,467.68 for laser compass 561-100 light green service contract supplies. Place of performance is Bethesda, MD 20892. The order has an ultimate completion date of October 31, 2020, and is priced on a firm fixed price basis with four quarterly payments of $8,116.92 each. The delivery order is issued under the GSA Schedule Scientific Equipment and...